Resources
Wegovy and disordered eating
Wegovy is semaglutide, the same drug as Ozempic, but approved specifically for chronic weight management rather than diabetes.12 That distinction is the whole point of this page. Because Wegovy's purpose is weight loss, it is used in a context centered on reducing weight, which makes the line between legitimate medical treatment and disordered eating especially worth watching. This page focuses on that line: why the weight-loss framing raises the stakes, who needs careful evaluation first, and when use has tipped into something disordered. For the drug-class overview, see Ozempic and eating disorders; for the molecule and the evidence, see semaglutide and eating disorder risk.
Why the weight-loss context matters
A medication taken to manage diabetes and a medication taken to lose weight can be the same molecule and still sit in very different psychological places. Wegovy is prescribed to reduce weight, so it is often used by people already focused on their weight, sometimes including people with underlying body-image distress or a long history of dieting.3 That focus is exactly what disordered eating develops from. The drug's appetite suppression can then make under-eating feel easy and natural, which is reinforcing in a way that is hard to recognize in yourself.2
This is not an argument that Wegovy is wrong for everyone. For people who meet the medical criteria, have no eating disorder vulnerability, and use it under supervision, it is a legitimate treatment that can address real health risks.1 The point is narrower: the weight-loss framing raises the stakes for screening before treatment and monitoring during it.
The line between treatment and disordered use
It helps to name what separates appropriate use from disordered use, because the dose is the same in both. The difference is the relationship with eating and weight that grows up around the medication.
| Appropriate medical use | Drifting toward disordered | |
|---|---|---|
| Goal | Treating a defined health risk under supervision | Getting smaller, with weight as the goal in itself |
| Eating | Eating enough even when appetite is low | Using the appetite loss to eat far less than the body needs |
| If stopping | Manageable, discussed with the prescriber | Fear or panic at the idea of stopping |
| Mindset | Weight is one health factor among several | Weight or the scale dominates daily thinking |
Who should be carefully evaluated first
Certain histories call for a careful eating disorder screen before Wegovy is started, not because treatment is necessarily wrong, but because the decision depends on the whole picture.
Eating disorder history
- A current or past eating disorder
- A family history of eating disorders
- Recovery that is recent or fragile
Related risk factors
- A history of chronic dieting, weight cycling, or body-image distress
- Seeking it for cosmetic rather than medical reasons
- Adolescence (see GLP-1 medications and teens)
When Wegovy use becomes disordered
The shift is usually gradual. Watch for using the appetite suppression to eat far less than the body needs, intense fear of regaining weight, preoccupation with the scale, distress at the thought of stopping, or any return of eating disorder behaviors such as restriction, purging, or compulsive exercise. Our guide on the signs that weight-loss medication use has become disordered walks through these in detail.
Worried Wegovy has affected your eating?
Free and confidential. Call to be connected with a licensed eating disorder program.
Call (602) 834-4077What to do
If you recognize these signs in yourself or someone you love, talk to a qualified professional: the prescriber, a primary care doctor, or an eating disorder specialist. Do not stop a prescribed medication abruptly without medical advice, because that carries its own risks, but do raise the concern clearly so it can be weighed properly. A brief self-assessment can be a starting point, though it is not a diagnosis.
Related reading
See semaglutide and eating disorder risk for the evidence, Ozempic and eating disorders for the overview, and GLP-1 medications and teens if a younger person is involved.
References
-
U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management (2021), approving Wegovy (semaglutide 2.4 mg) for chronic weight management in adults with obesity or overweight with at least one weight-related condition; see also Drugs@FDA prescribing information for Wegovy, which carries the approved indications, including the adolescent (ages 12 and older) indication. ↩ ↩
-
Semaglutide. StatPearls, National Center for Biotechnology Information (NCBI Bookshelf); semaglutide is the GLP-1 receptor agonist marketed as both Ozempic (type 2 diabetes) and Wegovy (chronic weight management), and it reduces body weight by suppressing appetite, increasing satiety, and delaying gastric emptying. ↩ ↩
-
National Eating Disorders Association. nationaleatingdisorders.org; National Institute of Mental Health. Eating Disorders. ↩
Common questions
What is Wegovy?
Wegovy is semaglutide approved for chronic weight management in people who meet certain medical criteria. It is the same drug as Ozempic, but Ozempic is approved for type 2 diabetes while Wegovy is approved specifically for weight loss.
Why does Wegovy raise disordered-eating concerns specifically?
Because its entire purpose is weight reduction, Wegovy is used in a context focused on losing weight, which can blur the line between medical treatment and disordered eating, especially for people already vulnerable to it. The drug itself is identical to Ozempic, but the weight-loss framing changes the psychology around it.
Who is Wegovy prescribed for?
It is approved for chronic weight management in people meeting specific medical criteria, used alongside diet and activity changes under medical supervision. It is not intended for cosmetic weight loss, and it calls for careful evaluation in anyone with eating disorder vulnerability.
Is Wegovy approved for teens?
Semaglutide is approved for chronic weight management in some adolescents aged 12 and older who meet specific criteria. Approval does not erase the eating disorder concerns, which are heightened in adolescence. See our page on GLP-1 medications and teens.
When does Wegovy use become disordered?
When it is paired with eating far less than the body needs, intense fear of regaining weight, preoccupation with the scale, or distress at stopping. Several of those signs together warrant a conversation with a professional.
Talk to a licensed eating disorder program
Free and confidential. Call to be connected with a program that fits, no obligation.
Call (602) 834-4077